Key result
Carotid intima-media thickness (CIMT) is a well-validated surrogate marker with potential usefulness as a risk marker in clinical programs for cardiovascular disease prevention.
Design
Review
Authors
Loading...
May support CIMT in CVD prevention programs; leaves open prospective outcome validation.
This review highlights the potential of carotid intima-media thickness (CIMT) as a non-invasive surrogate marker for individual cardiovascular disease risk assessment and prevention.
Verhamme et al. (2010) conducted a review in Cardiovascular disease. Carotid intima-media thickness (CIMT) was evaluated. Carotid intima-media thickness (CIMT) is a well-validated surrogate marker with potential usefulness as a risk marker in clinical programs for cardiovascular disease prevention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: